(Q37430181)

English

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

scientific article published on 07 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

sevelamer carbonate

1 reference

based on heuristic

inferred from title

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Stanley Fan

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Calum Ross

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sandip Mitra

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Philip Kalra

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jeremy Heaton

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

John Hunter

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Melissa Plone

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nick Pritchard

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

7 August 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

24

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3794-3799

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

23 August 2017

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

23 August 2017

The role of metabolic acidosis in the pathogenesis of renal osteodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

14 September 2017

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

26 June 2018

A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 September 2018

Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 September 2018

Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 September 2018

Medication knowledge and compliance among patients receiving long-term dialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 September 2018

Sevelamer worsens metabolic acidosis in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 October 2018

A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 October 2018

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2781155

2 October 2018

Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19666658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19666658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19666658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19666658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Problems when swallowing tablets. A questionnaire study from general practice]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19666658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NDT/GFP372

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37430181&oldid=2165562169"